72.11.Z - Scientific research and development activities
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 6,5 | 6,8 | 6,7 | -1,6 |
Gross profit (loss) | -0,6 | -0,3 | -0,3 | 4,2 |
Net profit (loss) | -0,6 | -0,3 | -0,3 | 4,2 |
Cash | 0,1 | 1,6 | 0,1 | -93,4 |
Net income from sale | 0 | 0,1 | 0 | -50 |
Liabilities and provisions for liabilities | 6,2 | 5,7 | 5,9 | 3 |
Short time liabilities | 1,3 | 0,5 | 0,8 | 46,7 |
Working assets | 0,2 | 2 | 0,4 | -81,4 |
Equity capital | 0,2 | 1,1 | 0,8 | -25,2 |
Operating profit (EBIT) | -0,6 | -0,3 | -0,2 | 26,1 |
% | % | % | p.p. | |
Profitability of capital | -284,7 | -27,2 | -34,8 | -7,6 |
Equity capital to total assets | 3,5 | 16,3 | 12,4 | -3,9 |
Gross profit margin | -501,6 | -960,7 | -459,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 3147 | 9233 | 6086 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane